Combined chemotherapy including high-dose methotrexate in KSHV/HHV8-associated primary effusion lymphoma.
about
How I treat HIV-associated lymphomaDrug sensitivity patterns of HHV8 carrying body cavity lymphoma cell lines.CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options.EBV and HIV-Related LymphomaKSHV/HHV8-associated lymphomas.Combination of arsenic and interferon-α inhibits expression of KSHV latent transcripts and synergistically improves survival of mice with primary effusion lymphomasReactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas.Therapeutic options for human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus-related disorders.Comparison of human herpes virus 8 related primary effusion lymphoma with human herpes virus 8 unrelated primary effusion lymphoma-like lymphoma on the basis of HIV: report of 2 cases and review of 212 cases in the literature.Extracavitary manifestation of primary effusion lymphoma as a right atrial mass.Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitorsUse of cidofovir for the treatment of HIV-negative human herpes virus-8-associated primary effusion lymphoma.Therapeutic options for HIV-associated lymphomas.Primary effusion lymphoma in an elderly patient effectively treated by lenalidomide: case report and review of literature.Primary effusion lymphoma in the absence of HIV infection--clinical presentation and management.KSHV-associated extracavitary primary effusion lymphoma in an HIV seronegative patient: a case report and review of the literature.Therapeutic effects of γ-irradiation in a primary effusion lymphoma mouse modelClassic and extracavitary primary effusion lymphoma in 51 HIV-infected patients from a single institution.Kaposi's sarcoma herpesvirus lytic replication compromises apoptotic response to p53 reactivation in virus-induced lymphomas.Primary effusion lymphoma: current perspectives.Human Herpesvirus 8 and Lymphoproliferative Disorders
P2860
Q26821860-D3A74B4D-E573-45AA-A9EA-A6C7058E902CQ34047294-1D9123E2-672C-4B05-BBC7-3B6E3CFFBA44Q34460823-DD8EEC0C-F6A8-4BEF-96D6-3F56CCB38610Q34549450-640E3AAF-B76F-49CE-959A-3561C0DE6CA6Q34711929-271B9D2B-AD58-4DFF-B54A-1BCD6495833BQ35046691-9FB58937-793D-4EEA-A148-09D9CA1BAAB8Q35664106-E4A29CEB-32E2-4ADD-92F8-68B477B46565Q35917368-12FF18EC-8109-4528-9850-D65AB9A5504BQ36668747-83B5D2CD-6963-4851-91F5-96979BA2B1B1Q36744331-B532B766-9FD3-4B1D-86ED-D45E962CE4D5Q36968066-34D79556-4B98-4BA1-BD59-CB01BA414230Q37765465-A8F19058-AC3C-454A-93C0-17F4B5AD1C07Q37781368-C483DF42-EEA9-4B72-9C82-40ECF2251EDCQ38194434-9FB60C7D-A95E-436C-BE4C-D72FDEFC4D38Q38270091-6917F13F-35D9-44C9-868B-D3C0DC306A8AQ39103251-2D921748-4CDE-4B84-BE73-39779D15D994Q39757410-ACEBD8D8-1297-4E87-BEDE-1E0A2778CEC7Q40821708-60441206-C7DE-4FC8-8A01-9372B05150EFQ45358610-5B53CD33-85BF-44FB-99AD-1E9B528BB6B2Q55518093-31B3484B-5B28-4F04-AD65-D8B0983338D3Q58701113-E6B66EFC-6344-4C88-AB1C-6A1673471C15
P2860
Combined chemotherapy including high-dose methotrexate in KSHV/HHV8-associated primary effusion lymphoma.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Combined chemotherapy includin ...... ted primary effusion lymphoma.
@ast
Combined chemotherapy includin ...... ted primary effusion lymphoma.
@en
type
label
Combined chemotherapy includin ...... ted primary effusion lymphoma.
@ast
Combined chemotherapy includin ...... ted primary effusion lymphoma.
@en
prefLabel
Combined chemotherapy includin ...... ted primary effusion lymphoma.
@ast
Combined chemotherapy includin ...... ted primary effusion lymphoma.
@en
P2093
P356
P1476
Combined chemotherapy includin ...... ted primary effusion lymphoma.
@en
P2093
Emmanuelle Boulanger
Eric Oksenhendler
Félix Agbalika
Marie-Thérèse Daniel
P304
P356
10.1002/AJH.10341
P577
2003-07-01T00:00:00Z